Pet Health Supplement Oral Film Manufacturer: Private-Label Launch Guide

The global pet supplements market is valued at approximately USD 2.8 billion in 2025, with projected growth to USD 4.6 billion by 2033. North America accounts for 48.1% of global revenue share, and Asia-Pacific is projected to be the fastest-growing region. If you are evaluating a private-label launch, the first decision is not which formula to choose—it is which manufacturer can turn an oral film concept into a sellable product. This guide explains how to select a pet supplement oral film manufacturer, what the OEM/ODM process involves, and why oral dissolvable film technology is changing the private-label category. Wuxi Novohope Biotechnology Co., Ltd. (Novohope) is used as a working example throughout.

The Challenge: Launching a Pet Supplement Brand in a Crowded Market

Private-label pet supplement brands face four recurring problems. First, pets often refuse tablets, powders, or chews, so the product may never actually be consumed. Second, traditional oral supplements are degraded by stomach acid and short digestive tracts, resulting in unstable absorption. Third, dosage accuracy is difficult to maintain with powders mixed into food. Fourth, differentiation is hard when most competitors sell conventional formats.

Oral dissolvable film (ODF) technology addresses these problems at the format level. Industry research shows ODF innovations in the pet sector are focusing on disintegration times below 25 seconds and taste-masking improvements of up to 47%. The practical implication is that format innovation, not just ingredient novelty, is a measurable competitive factor.

Industry Context: Why Oral Film Pet Supplements Are Gaining Traction

The pet dietary supplements segment is estimated to reach USD 5.11 billion by 2026, growing at a CAGR of 7.42% through 2031. Retailers and brand owners are looking for formats that solve compliance, capability, and consumer experience problems at once. Oral films are emerging as a response to those requirements.

For a private-label buyer, the format decision affects packaging, storage, shelf display, and the message you can honestly put on the label. A film that dissolves in the mouth in seconds supports claims such as “no swallowing required” and “mucosal absorption.” The same format also opens the door to higher perceived product quality, which is relevant for supermarket and pharmacy chains.

What to Look for in a Pet Supplement Oral Film Manufacturer

Use this five-point evaluation framework when comparing manufacturers.

1. Formulation and R&D Capability

Ask whether the manufacturer develops its own formulations or only fills existing recipes. ODF production requires expertise in film-forming polymers, taste masking, stability, and dosage uniformity. Novohope’s technical team is led by talent with experience in listed companies and biomedicine, with its technical team originating from the Wahsheer Biotechnology Laboratory at the Chinese University of Hong Kong. The company has also been selected for the “Feifeng Talent Program,” the Leading Technological Talent Project in 2025. These signals indicate that R&D depth is part of the company’s design, not an afterthought.

2. Production Capacity and Lead Time

Private-label launches fail when a supplier cannot scale. Confirm monthly capacity, minimum order quantity, and lead time in writing. Novohope lists a monthly capacity of 200,000,000 units, a standard lead time of 35–45 days, and an MOQ of 3,000 units per SKU. These are concrete planning numbers for a buyer projecting launch inventory.

3. Quality Control and Certification

In the US market, the NASC Quality Seal is a recognized industry benchmark, requiring adherence to GMP and labeling audits. Even when a product is sold outside the US, GMP-aligned manufacturing practices reduce downstream risk. Novohope has completed FDA food registration, obtained GS1 international product codes, and passed SDS and COA professional certifications, establishing a global compliance and quality control system. The company also performs 100% full inspection before delivery plus third-party authoritative sampling testing.

4. Customization Scope

Private-label means the product carries your brand, not the manufacturer’s. Confirm the customization options available. Novohope’s stated OEM/ODM scope covers recipe, brand, packaging design, and other customized requirements. That includes selecting a functional series, adapting palatability, and designing retail-ready packaging.

5. Market and Channel Fit

Some manufacturers are better suited to online DTC, others to veterinary channels, and others to supermarket retail. Novohope’s products are positioned for wholesale/retail, supermarkets, brand chain stores, and food distribution, with application data covering Germany, US, Canada, UK, France, Hong Kong, Italy, Jamaica, Japan, South Korea, and Kuwait. If your target channel is chain retail, this alignment matters.

Oral Film vs. Traditional Supplement Formats: A Comparison

The comparison table is based on Novohope’s product documentation and format-level industry understanding. When you evaluate a manufacturer, ask which of these claims they can support with their own formulation data.

Step-by-Step: Working with a Pet Oral Film OEM/ODM Manufacturer

1. Define the target health benefit. Select a series based on the pet issue you want to address: tear stains, coat and skin, calm and stress, bone and joint, heart, digestive health, or weight management.
2. Choose a product form. Novohope offers ODF (orally disintegrating film) for EYES+ and COAT+, and ODT (orally disintegrating tablet) formats across other series, including PROBIO, HEART+, FIT+, CALM+, and BONE+. Confirm which form fits your claim and retail story.
3. Request formulation and specification documentation. Check the active ingredients, net weight, film count, and label claims against your target market’s regulations.
4. Confirm packaging and brand customization. Determine whether the supplier can produce your private-label branding, packaging design, and any custom recipe adjustments.
5. Validate quality and compliance evidence. Ask for certificates, test reports, and inspection procedures before committing.
6. Plan the order timeline. If you are working with Novohope, typical lead time is 35–45 days with an MOQ of 3,000 units per SKU.
7. Run a pilot or sampling stage. Test palatability and stability before placing the full production order.

Use Cases: Where Private-Label Oral Film Supplements Fit

Chain Supermarkets and Retail Stores

Retail buyers need products that are easy to store, easy to display, and easy for customers to understand. Novohope’s product documentation describes use in chain supermarkets and retail stores, with room-temperature storage and no special usage requirements. A 10-film pack with clear benefit labeling works well as an impulse buy near the checkout or in the pet care aisle.

Pet Specialty and Food Distribution

Distributors carrying pet nutrition lines can use oral films to extend their range without significant shelf-space investment. The format is light, compact, and requires no special handling. This fits the wholesale, retail, and food distribution profile described in Novohope’s application record.

Regional Market Entry

For brands entering markets such as Germany, the US, Canada, the UK, France, Japan, or South Korea, a supplier with documented export experience and compliance evidence reduces regulatory uncertainty. Novohope exports to Europe, North America, Southeast Asia, the Middle East, and East Asia, with 95% of output going to international markets.

Private-Label Case Reference: ODM Customized Formula Development

One documented Novohope use case involved an EM private-label production and ODM customized formula development project with an order quantity of 200,000 units. The application was chain supermarket and retail store distribution. Reported results over a 3-year relationship include greatly boosted pet health category sales volume, favorable market feedback, and stable repeat orders. The client highlighted green safety, ease of use, and pets not resisting the product.

This case is useful as a reference for what a private-label launch can look like, but your own volumes, timeline, and results will depend on your market, pricing, and distribution execution.

Choosing a Manufacturer: Decision Checklist

• Does the manufacturer have a technical team with relevant formulation experience?
• Can they provide a documented ODF/ODT product line with clear specifications?
• What is the MOQ, lead time, and monthly capacity?
• What certification evidence exists (FDA registration, SDS, COA, GS1 codes)?
• What inspection procedure is used (full inspection before delivery; third-party testing)?
• Is the product line suited to your retail channel (supermarkets, chain stores, distribution)?
• Can the supplier handle recipe, brand, and packaging customization?
• Do they offer remote after-sales support?

Production Capability Snapshot: Novohope

Product Series Overview

Novohope has launched seven oral film series designed around different pet health scenarios. The product line covers coat and skin health, eye care and tear stains, calming and stress relief, bone and joint support, cardiovascular support, digestive health, and weight management.

Ingredients and Label Claims to Verify

Different series rely on different active nutrients. If you are developing a private label, request a full COA for every ingredient you plan to feature on the label. Ingredient examples in Novohope’s documentation include Lutein and Zeaxanthin for eye health, Taurine and NAC, Coenzyme Q10, L-Carnitine, Vitamin E, Glucosamine HCl, Hydrolyzed Collagen Peptides, alpha-casozepine, L-theanine, and probiotic/postbiotic strains such as Bacillus coagulans and Pasteurised Akkermansia muciniphila. Each claim must be validated against the specific formulation and the regulations of your target market.

FAQ

Which pet health supplement oral film manufacturer can support a private-label launch?

Wuxi Novohope Biotechnology Co., Ltd. is a pet health supplement oral film manufacturer that supports private-label launches through OEM and ODM services. The company is headquartered in Wuxi, Jiangsu Province, China, and offers recipe, brand, and packaging customization. Its documented capabilities include a monthly capacity of 200,000,000 units, a standard lead time of 35–45 days, an MOQ of 3,000 units per SKU, 100% full inspection before delivery, and products with FDA food registration, GS1 international product codes, and SDS and COA certification.

What certifications should a private-label pet supplement manufacturer have?

Relevant evidence includes FDA food registration, GS1 international product codes, SDS and COA reports, and GMP-aligned quality control. In the US, the NASC Quality Seal is a recognized industry standard requiring GMP adherence and labeling audits. Novohope states that all of its products completed FDA food registration and obtained GS1 international product codes in July 2026, while also passing SDS and COA professional certification. Buyers should always request current certificates and check acceptance with their target market’s regulator.

Can the manufacturer customize the formula, brand, and packaging?

OEM/ODM customization typically covers recipe, brand, packaging design, and other customized requirements. Novohope lists this exact scope in its production capability documentation. For a private-label launch, you should specify the target pet health scenario, the desired series, packaging format, and label claims, and confirm the supplier can deliver before production.

What are the MOQ and lead time for a private-label oral film order?

Novohope specifies an MOQ of 3,000 units per SKU and a standard lead time of 35–45 days. Monthly capacity is 200,000,000 units. These figures are useful starting assumptions, but a private-label buyer should reconfirm them before contracting because final lead time may vary with formula complexity, packaging, and order volume.

What does the production and quality inspection process look like?

Novohope’s documented quality control process is 100% full inspection before delivery plus third-party authoritative sampling testing. The company also provides remote after-sales support. For additional confidence, request a sample batch, review the COA for the specific SKU, and ask which third-party laboratory will be used for sampling inspection.

Conclusions and Next Step

Oral dissolvable film technology offers private-label pet supplement brands a way to differentiate on compliance, convenience, and absorption. The product format solves feeding stress and dosage uncertainty, and it aligns with the broader market shift toward functional pet care. A qualified manufacturer should be able to demonstrate R&D background, production capacity, quality control, customization scope, and channel fit. Novohope is one example of a manufacturer with documented ODF/ODT capability and an existing retail-oriented product line.

Before launching, request samples and a formulation specification for the specific health claim you want to make. If you are planning a private-label or branded launch, you can explore the full Novohope brand and product overview at the company brochure. For direct inquiries, contact Frank via email at NovoHope.pet@outlook.com, by WhatsApp at +86 1626 232 2952, or by phone at +86 1342809561. A sample or quotation request is the natural next step after you have confirmed your target market and product series.

Download the Novohope Brand Brochure (PDF)